Pioglitazone for the Treatment of Alcohol Use Disorder

2019-03-12 04:25:19 | BioPortfolio

Published on BioPortfolio: 2019-03-12T04:25:19-0400

Clinical Trials [3168 Associated Clinical Trials listed on BioPortfolio]

Study of the Effects of Motivational Enhancement Therapy on Alcohol Use in Chronic Hepatitis C Patients

The purpose of this study is to determine whether motivational enhancement therapy (MET) reduces alcohol use in a population of HCV-infected veterans who are currently drinking alcohol and...

Talk Therapy by Phone to Promote Treatment for Alcohol Problems

A small percentage of individuals with alcohol use disorder (AUD) obtain alcohol-related care despite research showing that treatment is effective. This randomized controlled trial tests t...

Medication and Counseling for Controlled Drinking (Project SMART)

The purpose of this study is to study the effectiveness of medication and specialized psychotherapy in helping gay and bisexual men who do not want to quit drinking learn how to reduce the...

Glutamatergic Modulation of Disordered Alcohol Use

Alcohol use disorders remain a significant public health problem. The pharmacological facilitation of behavioral treatment represents a promising strategy for addressing disordered drinkin...

Behavioral Therapy Plus Naltrexone for Alcoholism

This study will compare cognitive behavioral therapy with a time-limited motivational enhancement therapy to which naltrexone (Revia) or placebo medication is added. In this randomized c...

PubMed Articles [25646 Associated PubMed Articles listed on BioPortfolio]

ADHD Symptoms and Sex Moderate the Relation Between Protective Behavioral Strategies and Alcohol Use Among Treatment-Mandated College Students.

College students with attention deficit/hyperactivity disorder are likely to engage in alcohol use and experience alcohol-related problems. Use of protective behavioral strategies is related to fewer ...

Conquering the Craving: Treatment to Curb Alcohol Use Disorder.

Largely underutilized in North America, the use of medications to treat alcohol dependence is frequently a successful method of reducing alcohol craving and promoting abstinence. Recovery from alcohol...

Influence of comorbid drug use disorder on receipt of evidence-based treatment for alcohol use disorder among VA patients with alcohol use disorder and Hepatitis C and/or HIV.

Alcohol use is risky for patients with hepatitis C virus (HCV) and/or human immunodeficiency virus (HIV) infection, but alcohol use disorder (AUD) treatment is underutilized in these populations. Como...

Objective Continuous Monitoring of Alcohol Consumption for Three Months Among Alcohol Use Disorder Treatment Outpatients.

Transdermal alcohol sensing technology allows for objective continuous monitoring of alcohol use. The purpose of this study was to characterize alcohol consumption measured with this technology among ...

Predictive value of non-consumption outcome measures in alcohol use disorder treatment.

For decades, researchers have called for the systematic inclusion of non-consumption outcomes, such as alcohol-related consequences and, temptation/craving, in addition to consumption outcomes (e.g., ...

Medical and Biotech [MESH] Definitions

Distensibility measure of a chamber such as the lungs (LUNG COMPLIANCE) or bladder. Compliance is expressed as a change in volume per unit change in pressure.

Substances interfering with the metabolism of ethyl alcohol, causing unpleasant side effects thought to discourage the drinking of alcoholic beverages. Alcohol deterrents are used in the treatment of alcoholism.

Extent to which the patient follows prescribed treatment such as keeping APPOINTMENTS AND SCHEDULES and MEDICATION ADHERENCE for desired therapeutic outcome. It implies active responsibility shared by patient and health care providers.

The interdisciplinary field concerned with the development and integration of behavioral and biomedical science, knowledge, and techniques relevant to health and illness and the application of this knowledge and these techniques to prevention, diagnosis, treatment, and rehabilitation.

An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)

More From BioPortfolio on "Pioglitazone for the Treatment of Alcohol Use Disorder"

Quick Search


Searches Linking to this Trial